SCHEMBL3477835

SCHEMBL3477835

O=c1[c]c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722089 0.50
Benzoquinone SCHEMBL5308519 0.47 ALDH1A1 (1.00)
Benzoquinone SCHEMBL18103 0.47
SCHEMBL10426602 0.47
Ammonia Solution, Strong SCHEMBL722290 0.47
Benzoquinone SCHEMBL3208089 0.47
SCHEMBL29525411 0.45 KDM4E (0.40)
SCHEMBL29525891 0.45 KDM4E (0.40)
SCHEMBL12433546 0.45 KDM4E (0.40)
Benzoquinone SCHEMBL21494172 0.44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200283439-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2020-09-10 US disclosed
US-20190071443-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2019-03-07 US disclosed
US-20190048007-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2019-02-14 US disclosed
US-10118926-B2 Tricyclic quinoline and quinoxaline derivatives AbbVie Deutschland GmbH & Co. KG (DE) 2018-11-06 US disclosed
US-10088612-B2 Alkali-soluble resin, photosensitive resin composition for color filter containing the same and uses thereof CHI MEI CORPORATION (TW) 2018-10-02 US disclosed
US-9994568-B2 Tricyclic quinoline and quinoxaline derivatives AbbVie Deutschland GmbH & Co. KG (DE) 2018-06-12 US disclosed
EP-3116873-B1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL ABBVIE DEUTSCHLAND (DE) 2018-02-28 EP disclosed
EP-3116874-B1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL ABBVIE DEUTSCHLAND (DE) 2018-02-28 EP disclosed
US-20170158693-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL ABBVIE DEUTSCHLAND (DE) 2017-06-08 US disclosed
US-20170112851-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2017-04-27 US disclosed
US-20150259346-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 US disclosed
US-20150259343-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 US disclosed
EP-2895485-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2015-07-22 EP disclosed
US-20140080814-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-20 US disclosed
WO-2014041131-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-20 WO disclosed
US-20140080816-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-20 US disclosed
US-20140080813-A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES ABBVIE DEUTSCHLAND (DE) 2014-03-20 US disclosed
US-7842129-B2 Lacquer formulation for improving surface properties EVONIK DEGUSSA GMBH (DE) 2010-11-30 US disclosed
WO-2008107398-A2 PYRAZINE COMPOUNDS BASF SE (DE) 2008-09-12 WO disclosed
US-20050282022-A1 Coating formulation for improving surface properties DEGUSSA AG (DE) 2005-12-22 US disclosed